Is ALOSM.PA undervalued or overvalued?
As of 2025-03-25, the Intrinsic Value of Osmozis SAS (ALOSM.PA) is 15.17 EUR. This ALOSM.PA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 15.00 EUR, the upside of Osmozis SAS is 1.10%. This means that ALOSM.PA is undervalued by 1.10%.
The range of the Intrinsic Value is 13.08 - 17.37 EUR
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (184.38) - (17.77) | (29.59) | -297.3% |
| DCF (Growth 10y) | (11.48) - (86.18) | (16.83) | -212.2% |
| DCF (EBITDA 5y) | 13.08 - 17.37 | 15.17 | 1.1% |
| DCF (EBITDA 10y) | 16.08 - 23.16 | 19.44 | 29.6% |
| Fair Value | 1.55 - 1.55 | 1.55 | -89.69% |
| P/E | 3.64 - 9.73 | 6.20 | -58.7% |
| EV/EBITDA | 10.62 - 14.91 | 12.96 | -13.6% |
| EPV | 3.18 - 5.04 | 4.11 | -72.6% |
| DDM - Stable | 5.34 - 55.16 | 30.25 | 101.7% |
| DDM - Multi | 3.88 - 31.38 | 6.92 | -53.8% |
| Market Cap (mil) | 45.00 |
| Beta | -0.28 |
| Outstanding shares (mil) | 3.00 |
| Enterprise Value (mil) | 54.62 |
| Market risk premium | 5.82% |
| Cost of Equity | 6.09% |
| Cost of Debt | 5.00% |
| WACC | 5.57% |